Getting the right dose in cancer chemotherapy
Author Information
Author(s): Newell D R
Primary Institution: Cancer Research UK Developmental Therapeutics Programme, Medical School, University of Newcastle
Hypothesis
Is using body surface area the best method for calculating chemotherapy doses?
Conclusion
The reliance on body surface area for determining chemotherapy doses should be reconsidered in favor of more individualized approaches.
Supporting Evidence
- Using body surface area to calculate drug doses has been a long-standing practice despite its inaccuracies.
- Variability in drug clearance among patients is not solely related to body surface area.
- Gurney's paper provides rules for prescribing cytotoxic therapy doses that consider individual patient factors.
Takeaway
Doctors need to be careful when deciding how much chemotherapy to give patients, and just using body size might not be the best way to do it.
Potential Biases
There may be biases in relying on historical data and established practices for dosing.
Limitations
The article discusses the challenges of changing established dosing practices and the need for large trials to confirm safety.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website